Literature DB >> 12372732

Neonatal alloimmune thrombocytopenia: antenatal and postnatal imaging findings in the pediatric brain.

Sonia T Dale1, Lee T Coleman.   

Abstract

BACKGROUND AND
PURPOSE: Neonatal alloimmune thrombocytopenia (NAIT) is a maternal-fetal platelet antigen incompatibility disorder estimated to occur in one of 2000 to 5000 neonates. The diagnosis is made serologically by showing parental platelet antigen incompatibility and the presence of maternal platelet antibodies. In the absence of formalized antenatal screening, the radiologist has an important role to play in the recognition of this disorder, which has significant implications for the index case and any subsequent offspring. Our aim was to characterize the neuroradiologic findings and identify, if possible, a consistent pattern of neurologic injury typical of NAIT.
METHODS: We retrospectively reviewed the ultrasonograms, CT scans, MR images, and medical histories of six patients (21 weeks gestation to 9 years old) with intracranial injury secondary to serologically proved NAIT.
RESULTS: Hemispheric porencephalic cysts (n = 6), primarily located within a temporal lobe with extension into other lobes, were seen on the ultrasonograms, CT scans, and MR images of all six children. In five cases, this was thought to represent encephaloclastic porencephaly and, in one case, schizencephaly (agenetic porencephaly). Six children had ventriculomegaly of varying degrees and severity and asymmetry. Extra-axial hemorrhages (n = 2), intraventricular hemorrhage (n = 1), acute parenchymal hemorrhage (n = 2), and neuronal migrational disorder (n = 1) occurred with varying frequency.
CONCLUSION: Antenatal or early postnatal neuroradiologic imaging showing hemispheric porencephaly and lateral ventriculomegaly is a recognizable pattern of cerebral injury suggestive of the diagnosis of NAIT. In the absence of a cost-effective screening program of primiparous women and neonates for this disease, the radiologist has an important role to play in the recognition of this disease entity. It is crucial for the reporting radiologist to consider the possibility of NAIT in any child with antenatal hemorrhage and, more importantly, with the pattern of cerebral injury described above. Because a high percentage of subsequent pregnancies might be equally or more severely affected, antenatal management directed at preventing intracranial hemorrhages in utero has become of significant clinical importance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372732      PMCID: PMC7976783     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

Review 1.  Fetal alloimmune thrombocytopenia: consensus and controversy.

Authors:  J B Bussel; D W Skupski; J G MacFarland
Journal:  J Matern Fetal Med       Date:  1996 Sep-Oct

2.  Fetal alloimmune thrombocytopenia.

Authors:  J B Bussel; M R Zabusky; R L Berkowitz; J G McFarland
Journal:  N Engl J Med       Date:  1997-07-03       Impact factor: 91.245

3.  Clinical significance of fetal intracranial hemorrhage.

Authors:  P Vergani; N Strobelt; A Locatelli; G Paterlini; P Tagliabue; E Parravicini; A Ghidini
Journal:  Am J Obstet Gynecol       Date:  1996-09       Impact factor: 8.661

4.  Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group.

Authors:  M Dreyfus; C Kaplan; E Verdy; N Schlegel; I Durand-Zaleski; G Tchernia
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

5.  Porencephaly.

Authors:  J P Braun; A Tournade
Journal:  J Neuroradiol       Date:  1982       Impact factor: 3.447

6.  In utero cerebral hemorrhage in alloimmune thrombocytopenia.

Authors:  J H Herman; M I Jumbelic; R J Ancona; T S Kickler
Journal:  Am J Pediatr Hematol Oncol       Date:  1986

7.  Destructive lesions of the brain.

Authors:  C Raybaud
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

8.  Isoimmune neonatal thrombocytopenia: a case report and review.

Authors:  D Chandler; S J Daniel
Journal:  Am J Clin Pathol       Date:  1985-06       Impact factor: 2.493

Review 9.  Antepartum fetal intracranial hemorrhage, predisposing factors and prenatal sonography: a review.

Authors:  D M Sherer; A Anyaegbunam; C Onyeije
Journal:  Am J Perinatol       Date:  1998-07       Impact factor: 1.862

10.  Neonatal alloimmune thrombocytopenia in consecutive pregnancies.

Authors:  D S Seidman; B Chayen; J Kuint; S Mashiach; G Barkai
Journal:  J Perinat Med       Date:  1991       Impact factor: 1.901

View more
  5 in total

Review 1.  Findings and differential diagnosis of fetal intracranial haemorrhage and fetal ischaemic brain injury: what is the role of fetal MRI?

Authors:  Bryn Putbrese; Anne Kennedy
Journal:  Br J Radiol       Date:  2016-12-08       Impact factor: 3.039

2.  Deletion in COL4A2 is associated with a three-generation variable phenotype: from fetal to adult manifestations.

Authors:  Gustavo Malinger; Aviva Fattal-Valevski; Moran Hausman-Kedem; Liat Ben-Sira; Debora Kidron; Shay Ben-Shachar; Rachel Straussberg; Daphna Marom; Penina Ponger; Anat Bar-Shira
Journal:  Eur J Hum Genet       Date:  2021-04-09       Impact factor: 4.246

3.  Intracranial Hemorrhage and Autoimmune Thrombocytopenia in a Neonate: A Rare "Unpredictable" Event.

Authors:  Andrea Becocci; Cristina Felice-Civitillo; Méryle Laurent; Françoise Boehlen; Roberta De Luca; Joel Fluss
Journal:  Child Neurol Open       Date:  2018-04-05

4.  The spectrum of brain malformations and disruptions in twins.

Authors:  Kaylee B Park; Teresa Chapman; Kimberly A Aldinger; Ghayda M Mirzaa; Jordan Zeiger; Anita Beck; Ian A Glass; Robert F Hevner; Anna C Jansen; Desiree A Marshall; Renske Oegema; Elena Parrini; Russell P Saneto; Cynthia J Curry; Judith G Hall; Renzo Guerrini; Richard J Leventer; William B Dobyns
Journal:  Am J Med Genet A       Date:  2020-11-18       Impact factor: 2.802

Review 5.  Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention.

Authors:  Ewa Brojer; Anne Husebekk; Marzena Dębska; Małgorzata Uhrynowska; Katarzyna Guz; Agnieszka Orzińska; Romuald Dębski; Krystyna Maślanka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-11-12       Impact factor: 4.291

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.